Evidence

The need

for objective adherence monitoring

Adherence is a major problem for every medication. There is extensive literature demonstrating the negative impacts of poor adherence on the effectiveness of PrEP and HIV treatment. Objective adherence monitoring, like UrSure's tests, provides novel adherence insights.

Development of the UrSure tests

UrSure initially developed and validated a lab-based version of its test. Since then, it has also developed and validated a novel point of care version of its test. 

UrSure Assay for TFV to Monitor Adherence in real time to TDF/FTC as PrEP
Poster
Paper

2017 

UrSure tests have clinical impact

UrSure's tests have been used in clinical practice and research settings worldwide. To date, they have been associated with increases in adherence, and they can predict non-retention in care. 

Want to stay up to date with UrSure? Join our newsletter!
  • Twitter
  • LinkedIn
EMAIL icon white.png

©  2020 by UrSure, Inc., a wholly-owned subsidiary of OraSure Technologies, Inc., all rights reserved.